Hikal informs about analyst meet intimation

30 Jan 2023 Evaluate
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations), Hikal has informed that, the Company will hold the earnings conference call to discuss the financial and operational performance for the quarter and nine months ended December 31, 2022, on Thursday, February 2, 2023 at 04:30 PM IST. The details of the conference call including the dial-in details are attached herewith. This information is submitted pursuant to Regulation 30(6) of the SEBI Listing Regulations.

The above information is a part of company’s filings submitted to BSE.

Hikal Share Price

242.40 -10.55 (-4.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×